Ecolab (ECL) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Ecolab

NYSE•Basic Materials•Specialty Chemicals

$271.68-2.40(-0.01%)After hours

Market Cap

$75.92B

P/E

35.9x

P/S

4.5x

P/B

7.6x

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

How this company scores

GoodMetricSide Score: 66/100

Strongest: Cash & Earnings Quality (23/25); weakest: Balance Sheet & Red Flags (9/25).

Profitability19/25

Growth15/25

Balance Sheet & Red Flags9/25

Cash & Earnings Quality23/25

Strengths

Rising free cash flowStrong marginsHigh ROEConsistent free cash flow

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 35.9x5y range 31.5x – 59.4x

Currently near its 20-quarter median.

P/S · 4.5x5y range 2.9x – 5.3x

Currently near its 20-quarter median.

P/B · 7.6x5y range 5.7x – 9.3x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Margin Pressure

Watch

Operating margins declined 7.7% — watch for continued compression, which may signal competitive or cost pressure.

Leverage Risk

Watch

Debt-to-equity has risen 46.7% recently — increasing financial risk even if the current ratio is manageable.

Price & Volume

Market Cap $75.92B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $16.84B
Q. Revenue: $4.42B
TTM EBITDA: $3.87B
TTM Op. Income: $2.85B
Q. Op. Income: $757.90M
TTM Net Income: $2.12B
Q. Net Income: $534.90M
EPS: $1.91
Shares Out.: $280.70M

$16.84B in TTM revenue grew 7.1% YoY, reaching $4.42B last quarter. TTM EBITDA of $3.87B and TTM operating income of $2.85B show growth is flowing through to the bottom line. TTM net income of $2.12B means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 5 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 44.1%
EBITDA Margin: 19.1%
Op. Margin: 17.2%
Net Margin: 12.1%

Op. margin of 17.2% is down 0.5% YoY — costs are rising relative to revenue. Net margin at 12.1% and gross margin of 44.1% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 3% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 35.9x
P/S Ratio: 4.5x
P/B Ratio: 7.6x

At 35.9x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 4.5x and P/B of 7.6x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 0% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $29.93B
Cash: $5.14B
Long-Term Debt: $11.91B
Book Value: $10.06B
D/E Ratio: 1.2
Debt/EBITDA: 14.1

With $29.93B in assets and $11.91B in long-term debt, D/E is 1.2and book value is $10.06B — moderate leverage. Over the past year, debt/equity is up 47% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $729.50M
TTM Free Cash Flow: $1.87B
FCF Margin: 11.1%
FCF / Net Income: 0.9

TTM FCF of $1.87B on $729.50M in operating cash flow. The FCF / Net Income ratio of 0.9x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 19% — an improving trend.